A cost-effectiveness analysis of anemia screening before erythropoietin in patients with end-stage renal disease-Reference-Cited by-同舟云学术

A cost-effectiveness analysis of anemia screening before erythropoietin in patients with end-stage renal disease

Published:1997-05 Issue:5 Volume:29 Page:651-657
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Hutchison Florence N.,Jones Walter J.

Publisher

Elsevier BV

Subject

Nephrology

Reference26 articles.

1. Correction of anemia of end-stage renal disease with recombinant human erythropoietin;Eschbach,1987

2. Beneficial and adverse effects of correction of anaemia by recombinant human erythropoietin in patients on maintenance hemodialysis;Grutzmacher,1988

3. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin;Evans;JAMA,1990

4. Human Recombinant Erythropoietin Utilization in the Department of Veterans Affairs Dialysis Centers,1992

5. Iron status in patients receiving erythropoietin for dialysis-associated anemia;Van Wyck;Kidney Int,1989

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycemic Variability in Different Stages of Chronic Kidney Disease with Type 2 Diabetes Mellitus: A Cross-sectional Study;Indian Journal of Medical Biochemistry;2024-04-20

2. Anemia in Chronic Renal Disease;Pediatric Kidney Disease;2023

3. Red Blood Cell Lifespan Shortening in Patients with Early-Stage Chronic Kidney Disease;Kidney and Blood Pressure Research;2019

4. The association between corrected QT dispersion and iron parameters in hemodialysis diseases;Eurasian Journal of Medicine and Oncology;2017

5. Anemia in Chronic Renal Disease;Pediatric Kidney Disease;2016